PCN72 An EARLY Cost-Effectiveness Analysis of Xevinapant in Combination with Chemo-Radiotherapy in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck in United States.
Abstract
Authors
A. Gandola R. AIT Sarkouh P. Orfanos F. Bouisset L. Licitra